New Horizons in the Management of ADA-SCID, led by Andrew Gennery, Robbert Bredius and Bobby Gaspar, is a free resource designed to educate healthcare professionals who are presented with Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) patients.
New Horizons in the Management of ADA-SCID, focuses on the biology of the disease, how to screen for it, and current and emerging treatments.
Aimed at Immunologists, Gene and Cell Therapy Clinicians, Transplant Specialists, Paediatricians and Haematologists, the site provides:
Currently approved and standard of care therapies for ADA-SCID
And coming soon: